| First Author | Hernandez CM | Year | 2014 |
| Journal | J Physiol | Volume | 592 |
| Issue | 15 | Pages | 3201-14 |
| PubMed ID | 24879866 | Mgi Jnum | J:219327 |
| Mgi Id | MGI:5620285 | Doi | 10.1113/jphysiol.2014.272054 |
| Citation | Hernandez CM, et al. (2014) Research tool: Validation of floxed alpha7 nicotinic acetylcholine receptor conditional knockout mice using in vitro and in vivo approaches. J Physiol 592(Pt 15):3201-14 |
| abstractText | There is much interest in alpha7 nicotinic acetylcholine receptors (nAChRs) in CNS function since they are found throughout peripheral tissues as well as being highly expressed in brain regions implicated in attention, learning and memory. As such, the role of these receptors in many aspects of CNS function and disease is being actively investigated. To date, only one null mouse model (A7KO) is available which is non-conditional and constitutive. Since alpha7 nAChRs are present on neurons and glia (including astrocytes), as well as being developmentally regulated, there is an unmet need for the technical capability to control alpha7 nAChR gene expression. Therefore we have generated mice in which the fourth exon of the alpha7 nAChR gene (Chrna7) is flanked by loxP sites (B6-Chrna7(LBDEx4007Ehs)) which we refer to as floxed alpha7 nAChR conditional knockout or alpha7nAChR(flox). We validated the chosen approach by mating alpha7nAChR(flox) with mice expressing Cre recombinase driven by the glial acidic fibrillary protein (GFAP)-Cre promoter (GFAP-A7KO) to test whether alpha7nAChR(flox), GFAP-A7KO and appropriate littermate controls performed equally in our standard Rodent In Vivo Assessment Core battery to assess general health, locomotion, emotional and cognitive behaviours. Neither alpha7nAChR(flox) nor GFAP-A7KO exhibited significant differences from littermate controls in any of the baseline behavioural assessments we conducted, similar to the 'first generation' non-conditional A7KO mice. We also determined that alpha7 nAChR binding sites were absent on GFAP-positive astrocytes in hippocampal slices obtained from GFAP-A7KO offspring from alpha7nAChR(flox) and GFAP-Cre crosses. Finally, we validated that Cre recombinase (Cre)-mediated excision led to functional, cell- and tissue-specific loss of alpha7 nAChRs by demonstrating that choline-induced alpha7 nAChR currents were present in Cre-negative, but not synapsin promoter-driven Cre-positive, CA1 pyramidal neurons. Additionally, electrophysiological characterization of alpha7 nAChR-mediated current traces was similar in terms of amplitude and time constants of decay (during desensitization) for the alpha7nAChR(flox) and wild-type (WT) mice. Thus, we have in vivo and in vitro evidence that the Chrna7 exon 4 targeting strategy does not alter behavioural, cognitive, or electrophysiological properties compared to WT and that Cre-mediated excision is an effective approach to delete alpha7 nAChR expression in a cell-specific manner. |
